ARCHIVES

Two Groups Take Different Approaches To Toxicity Of Saltz Regimen In Studies

This article is from The Cancer Letter archive.

Vol. 24 No. 6 | June 29, 2001

Download PDF Visit The Full Archive

Related Articles

Tamoxifen Trial Enrolls 19% Of Women Needed, Fisher Reports To NCAB

October 16, 1992

President’s Budget Takes Care If R01s, P01s, Fattens Up NTP, Devastates Construction Grants

February 1, 1980

FDA Approves Avastin Combination For Late-Stage Cervical Cancer

August 29, 2014

DCPC Board Agrees to Commit $62 Million To Trials Of Prostate, Lung, Colorectal Cancer Screening

October 20, 1989

Beta Blockers Negate Harmful Recurrence Risks of ACE Inhibitors

April 29, 2011

Research Contracts Branch Reorganized, Graalman On “Detail”

October 22, 1982